Stocks To Watch: Domestic stock markets are likely to start the first session of December 2020 on a positive note, after official macroeconomic showed the country's GDP contracted a better-than-expected 7.5 per cent in the July-September period. The Singapore Exchange's Nifty futures - an early indicator of the National Stock Exchange's Nifty 50 benchmark index - rose 28.8 points, or 0.22 per cent, to touch 13,025.80 at the strongest level recorded ahead of the opening of Indian markets. At 8:43 am, the SGX Nifty futures traded 12.00 points or 0.09 per cent higher at 13,009.00.
Market participants awaited the RBI's scheduled bi-monthly policy review due later this week for near-term triggers. (Catch Latest Market Updates Here)
Here are few stocks that will be in focus in Tuesday's (December 1) session:
Tata Consultancy Services (TCS) shares will be in focus today, after the country's largest software services firm launched a curated version of its Data and Analytics Target Operating Model (TCS DATOM) consulting framework, to help customers fully leverage data and analytics to drive superior business transformation outcomes with Microsoft Azure.
TCS DATOM provides context-based details on the implementation of data and analytics programs with a composite service delivery model, empowering organizations to achieve their business goals with clear definitions of the technology, processes, roadmap, and competency.
Auto stocks, including M&M, Tata Motors, Bajaj Auto, Maruti Suzuki, TVS Motor, Hero MotoCorp and Ashok Leyland, would be in the limelight as these companies would be releasing their November sales data during the day.
ICICI Lombard General Insurance
ICICI Lombard General Insurance Company shares could see some action after the company received an in-principle approval from the Insurance Regulatory and Development Authority of India to the draft scheme of arrangement between itself and and Bharti AXA General Insurance Company.
Glenmark Pharma shares are likely to witness investor interest after the pharma company announced, on Saturday, that it would be divesting select anti-allergy brands to Dr Reddy's in Russia and Ukraine.